Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronda L Simpson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|November 13, 2014
Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α)Sudhir Singh, Ronda L Simpson, Robert G Bennett
World Journal of Gastroenterology|June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisRobert G Bennett, Ronda L Simpson, Frederick G Hamel
Biology|July 8, 2020
A Selective PPARγ Modulator Reduces Hepatic FibrosisBenita L McVicker, Frederick G Hamel, Ronda L Simpson, et al.
Biology|October 27, 2023
Reduction in Obesity-Related Hepatic Fibrosis by SR1664Benita L McVicker, Ronda L Simpson, Frederick G Hamel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Relaxin decreases the severity of established hepatic fibrosis in miceRobert G Bennett, Dean G Heimann, Sudhir Singh, et al.
Biochemical and Biophysical Research Communications|June 24, 2014
Ethanol affects hepatitis C pathogenesis: humanized SCID Alb-uPA mouse modelNatalia A Osna, Kusum K Kharbanda, Yimin Sun, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|November 13, 2014
Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α)Sudhir Singh, Ronda L Simpson, Robert G Bennett
World Journal of Gastroenterology|June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisRobert G Bennett, Ronda L Simpson, Frederick G Hamel
Biology|July 8, 2020
A Selective PPARγ Modulator Reduces Hepatic FibrosisBenita L McVicker, Frederick G Hamel, Ronda L Simpson, et al.
Biology|October 27, 2023
Reduction in Obesity-Related Hepatic Fibrosis by SR1664Benita L McVicker, Ronda L Simpson, Frederick G Hamel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Relaxin decreases the severity of established hepatic fibrosis in miceRobert G Bennett, Dean G Heimann, Sudhir Singh, et al.
Biochemical and Biophysical Research Communications|June 24, 2014
Ethanol affects hepatitis C pathogenesis: humanized SCID Alb-uPA mouse modelNatalia A Osna, Kusum K Kharbanda, Yimin Sun, et al.
Pageof 1